Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Abatacept, rituximab or tocilizumab
(Synonym: D02994)		[3] Abatacept,
Rituximab,
Tocilizumab		[3] D02596 ,
D02994 ,
D03203 		[4] CD80,
CD86,
IL6R,
MS4A1 💬		[24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46
2ABP 798 - Biosimilar to rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
3ABP 798 Biosimilar to Rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
4Administration of rituximab and methylprednisolone
(Synonym: D02994)		[2] Methylprednisolone,
Rituximab		[7] D00407 ,
D00751 ,
D00979 ,
D02994 ,
D05000 ,
D05001 ,
D05002 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 51
5Alemtuzumab and Rituximab
(Synonym: D02994)		[2] Alemtuzumab,
Rituximab		[2] D02802 ,
D02994 		[2] CD52,
MS4A1 💬		-[1] 60
6Alemtuzumab, Rituximab
(Synonym: D02994)		[2] Alemtuzumab,
Rituximab		[2] D02802 ,
D02994 		[2] CD52,
MS4A1 💬		-[1] 63
7Bendamustine, Rituximab
(Synonym: D02994)		[2] Bendamustine,
Rituximab		[2] D02994 ,
D07501 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 61
8Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
(Synonym: D02994)		[3] Azathioprine,
Dexamethasone,
Rituximab		[12] D00238 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 ,
D03033 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 35
9Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 85
10Dexamethasone and Rituximab
(Synonym: D02994)		[2] Dexamethasone,
Rituximab		[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63
11Double-Blind Rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 51
12Dr. Reddy’s Rituximab (DRL_RI) 100mg
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
13Dr. Reddy’s Rituximab (DRL_RI) 500mg
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
14Eltrombopag combining rituximab
(Synonym: D02994)		[2] Eltrombopag,
Rituximab		[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 63
15Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab
(Synonym: D02994)		[4] Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		[4] D02596 ,
D02994 ,
D03203 ,
D10161 		[4] CD80,
CD86,
IL6R,
MS4A1 💬		[24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46
16Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 222
17GP2013 - A Proposed biosimilar rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
18IDEC-C2B8 (rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
19Immunosuppressive treatment (eg, rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 64
20Individualized dose of rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 49
21Intravenous Rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 66
22MabionCD20 (candidate biosimilar to rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
23MabThera (Rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[4] 13, 46, 49, 53
24Mabthera or biosimilar Rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 61
25Mabthera or biosimilar rituximab product
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
26MabThera® (rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
27Originator rituximab - Rituxan ® or MabThera ®
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
28Prednisone, low dose rituximab
(Synonym: D02994)		[2] Prednisone,
Rituximab		[2] D00473 ,
D02994 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
29RhTPO in combination with Rituximab
(Synonym: D02994)		[2] Recombinant Human Thrombopoietin,
Rituximab		[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 63
30Rituxan (INN: Rituximab), brand name in the United States
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
31Rituxan (INN: Rituximab), brand name in the US
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
32Rituxan (rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 49
33Rituxan® (rituximab)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
34Rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[49] 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
35Rituximab (anti-CD20)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 53
36Rituximab (Arm A)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 43, 44
37Rituximab (Arm B)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 43, 44
38Rituximab (EU)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
39Rituximab (genetical recombination)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 14
40Rituximab (MABTHERA® or RITUXAN®).
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 35, 61
41Rituximab (Mabthera®)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 61
42Rituximab (Rituxan)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 11
43Rituximab (RTX) and Azathioprine (AZA)
(Synonym: D02994)		[2] Azathioprine,
Rituximab		[3] D00238 ,
D02994 ,
D03033 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 65
44Rituximab (US)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
45Rituximab - MabThera
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
46Rituximab 1g IV
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 162
47Rituximab [MabThera/Rituxan]
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 46, 63
48Rituximab [MabThera]
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
49Rituximab and Cyclophosphamide IV
(Synonym: D02994)		[2] Cyclophosphamide,
Rituximab		[3] D00287 ,
D02994 ,
D07760 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 35
50Rituximab and Hyaluronidase Human
(Synonym: D02994)		[2] Hyaluronidase,
Rituximab		[4] D02994 ,
D04455 ,
D04456 ,
D06604 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 331
51Rituximab combined with Omalizumab
(Synonym: D02994)		[2] Omalizumab,
Rituximab		[2] D02994 ,
D05251 		[2] FCER1A,
MS4A1 💬		[5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 162
52Rituximab Infusion
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 13, 222
53Rituximab IT
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
54Rituximab IV
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
55Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
56Rituximab MabThera
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
57Rituximab, Mabthera
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 53
58Rituximab, MTX, folic acid
(Synonym: D02994)		[2] Folic acid,
Rituximab		[2] D00070 ,
D02994 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
59Rituximab, observational study amon patients with active RA
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
60Rituximab-EU+ Rituximab-Pfizer x 2 Courses
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
61Rituximab-Pfizer
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
62Rituximab-Pfizer (PF-05280586) x 3 courses
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
63Rituximab-US + Rituximab-Pfizer x 2 Courses
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
64Rituximab/ Mabthera
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 271
65SAIT101 (proposed rituximab biosimilar)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
66SAIT101 (rituximab biosimilar)
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
67Standard dose of rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 49
68The Standard Steroid Treatment, Plasma Exchange and rituximab
(Synonym: D02994)		[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 85